For a collaboration of Dr. Carolyn Bertozzi, Dr. Catherine Blish and Dr. Marie Hollenhorst to identify minimally invasive predictive biomarkers for Covid-19 disease progression to improve scarce resource allocation.
- Funded by Emergent Ventures Fast Grants
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
Emergent Ventures Fast GrantsPrincipal Investigator
Dr. Carolyn BertozziResearch Location
United States of AmericaLead Research Institution
Stanford UniversityResearch Priority Alignment
N/A
Research Category
Clinical characterisation and managementResearch Subcategory
Prognostic factors for disease severitySpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable